{"id":222559,"date":"2023-12-21T17:53:57","date_gmt":"2023-12-21T17:53:57","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=222559"},"modified":"2023-12-21T17:53:57","modified_gmt":"2023-12-21T17:53:57","slug":"sanofi-pune-capat-programului-de-dezvoltare-clinica-a-unui-medicament-impotriva-cancerului-dupa-ce-acesta-a-esuat-intr-un-stadiu-avansat-de-testare","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=222559","title":{"rendered":"Sanofi pune cap\u0103t programului de dezvoltare clinic\u0103 a unui medicament \u00eempotriva cancerului dup\u0103 ce acesta a e\u015fuat \u00eentr-un stadiu avansat de testare"},"content":{"rendered":"<p>\nSanofi a anun\u0163at c\u0103 va \u00eencheia un program de dezvoltare clinic\u0103 pentru medicamentul tusamitamab ravtansine, dup\u0103 ce un studiu \u00een stadiu avansat, efectuat pe pacien\u0163i cu cancer pulmonar, nu \u015fi-a atins obiectivul principal, potrivit Bloomberg.<\/p>\n<p>\nCompania farmaceutic\u0103 francez\u0103 a precizat c\u0103 decizia a fost luat\u0103 dup\u0103 ce un comitet independent de monitorizare a datelor a constatat c\u0103 tusamitamab ravtansine nu \u015fi-a putut atinge obiectivul principal. Studiul a avut obiective primare duble de supravie\u0163uire f\u0103r\u0103 progresie a bolii \u015fi de supravie\u0163uire general\u0103.<\/p>\n<p>\n\u00cen timp ce timpul de supravie\u0163uire al pacien\u0163ilor a fost \u00eembun\u0103t\u0103\u0163it, decizia privind studiul s-a bazat pe lipsa \u00eembun\u0103t\u0103\u0163irii supravie\u0163uirii f\u0103r\u0103 progresie a bolii, a declarat joi Sanofi.<\/p>\n<p>\nTusamitamab ravtansine a avut un profil de siguran\u0163\u0103 similar cu cel prezentat anterior, a precizat compania.<\/p>\n<p>\nSanofi a precizat c\u0103 va continua s\u0103 exploreze poten\u0163ialul conjugatelor medicamentoase pe baz\u0103 de anticorpi cu tusamitamab.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sanofi a anun\u0163at c\u0103 va \u00eencheia un program de dezvoltare clinic\u0103 pentru medicamentul tusamitamab ravtansine, dup\u0103 ce un studiu \u00een stadiu avansat, efectuat pe pacien\u0163i cu cancer pulmonar, nu \u015fi-a atins obiectivul principal, potrivit Bloomberg. Compania farmaceutic\u0103 francez\u0103 a precizat c\u0103 decizia a fost luat\u0103 dup\u0103 ce un comitet independent de monitorizare a datelor a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[14610,407,7442,39196,8088,25486,97,12923],"class_list":["post-222559","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-cancer","tag-clinica","tag-dezvoltare","tag-esuare","tag-farma","tag-sanofi","tag-testare","tag-tratament"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/222559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=222559"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/222559\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=222559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=222559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=222559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}